Skip to main content

9 Result(s)

within Tatjana Zabelina Remove this filter

and

  1. No Access

    Article

    Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis

    Splenomegaly is a hallmark of myelofibrosis (MF), and reports on the impact of spleen size on the outcome of allo-HSCT have been conflicting, possibly due to differences in methods of assessment. We retrospect...

    Marlene Luther, Frank Oliver Henes, Tatjana Zabelina… in Bone Marrow Transplantation (2023)

  2. Article

    Open Access

    Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML

    Allogeneic hematopoietic stem-cell transplantation (HSCT) remains the only curative option for patients with advanced chronic myeloid leukemia (CML). However, outcome is dismal and of short follow-up. The obje...

    Christian Niederwieser, Elena Morozova, Ludmila Zubarovskaya… in Bone Marrow Transplantation (2021)

    Download PDF (1067 KB) View Article

  3. No Access

    Article

    Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria

    Chronic graft versus host disease (cGvHD) is the most common cause of late morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). We retrospectively evaluated the impact of NI...

    Francis Ayuk, Ronja Veit, Tatjana Zabelina, Lara Bussmann… in Annals of Hematology (2015)

  4. No Access

    Article

    Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation

    In a retrospective single-centre study, we analysed the prognostic impact of factors identifiable at initial diagnosis of acute GVHD (aGVHD). We retrospectively analysed 495 adult patients of whom 308 (62 %) d...

    Francis Ayuk, Lara Bussmann, Tatjana Zabelina, Ronja Veit… in Annals of Hematology (2014)

  5. No Access

    Article

    Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

    The introduction of tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) led to a dramatic change in the role of allogeneic stem cell transplantation (SCT) with a rapid decline in the number of...

    Anthony Oyekunle, Axel R. Zander, Mascha Binder, Francis Ayuk… in Annals of Hematology (2013)

  6. No Access

    Article

    The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia—a report from the German Registry covering the period from 1998 to 2004

    Due to the recent changes in the indication to allogeneic stem cell transplantation (SCT) in chronic myeloid leukemia (CML), we retrospectively analyzed 1,716 patients with different CML stages who received an...

    Ulrike Bacher, Evgeny Klyuchnikov, Tatjana Zabelina… in Annals of Hematology (2009)

  7. No Access

    Chapter and Conference Paper

    Anti Thymocyte Globuline Allows for Successful Transplantation from HLA Mismatched Unrelated Donors

    Allogeneic hemopoietic stem cell transplantation of matched unrelated donors carries an increased risk of graft versus host disease (GvHD) and transplant related mortality (TRM). We introduced ATG Fresenius at...

    Dr. Axel R. Zander, Tatjana Zabelina… in Stem Cells and their Potential for Clinica… (2008)

  8. No Access

    Article

    Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)

    We investigated toxicity and efficacy of in vivo T-cell depletion with anti-thymocyte globulin (ATG) as part of an intensified myeloablative conditioning regimen followed by allogeneic stem cell transplantation i...

    Nicolaus Kröger, Hermann Einsele, Daniel Wolff… in Bone Marrow Transplantation (2003)

  9. No Access

    Article

    Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors

    To reduce the incidence of GvHD and the rate of graft failure in unrelated stem cell transplantation, we incorporate anti-thymocyte globulin in the preparative regimen in 98 patients with hematological or inhe...

    Nicolaus Kröger, Tatjana Zabelina, William Krüger, Helmut Renges… in Annals of Hematology (2001)